Grund Nicholas
Akebia Therapeutics, Inc. · Chief Commercial Officer
Grund Nicholas is listed in public filings as officer: Chief Commercial Officer. This Grund Nicholas insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Akebia Therapeutics, Inc. (AKBA). Investors use Grund Nicholas's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $824k593k shares | SellFeb 2, 2026 | $74.5K53.6k shares | $1.39 | -- | |
| $781k561.8k shares | SellFeb 2, 2026 | $43.4K31.2k shares | $1.39 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $451k320k shares | Grant / ExerciseJan 30, 2026 | $451.2K320k shares | $1.41 | -- | |
| --646.6k shares | Grant / ExerciseJan 30, 2026 | Disclosure amount unavailable204k shares | -- | -- | |
| $929k442.6k shares | SellFeb 3, 2025 | $116.8K55.6k shares | $2.10 | -- | |
| $655k292.3k shares | Grant / ExerciseJan 31, 2025 | $654.8K292.3k shares | $2.24 | -- | |
| --498.2k shares | Grant / ExerciseJan 31, 2025 | Disclosure amount unavailable194.9k shares | -- | -- |